Latest News
Dr. Barbara Burtness Receives Presidential Citation from AAO-HNS.
- April 29, 2024Source: ACS Journals
Dr. Barbara Burtness discusses how she has applied advances in molecular biology to better treat patients with head and neck cancers.
- April 17, 2024
Camille C. R. Ragin, PhD, MPH — a member of the collaborative SPORE research program for Head and Neck Cancer at Yale — was honored with a lectureship at this year's annual meeting of the American Association for Cancer Research (AACR).
- April 16, 2024
Curtis Pickering and the Yale Head and Neck SPORE organized the first symposium of the Yale-NY region on head and neck translational research at Yale West Campus on April 12, 2024.
- April 15, 2024
Reflecting the complexities of the disease, cancer research is an ever-evolving field requiring constant infusions of innovation and funding. Starting this year, those resources at Yale Cancer Center will be augmented by its Translational Incubator, an initiative to further support and accelerate cooperation and collaboration among Yale experts.
- April 02, 2024
A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024
- March 18, 2024
On March 15, 2024, Dr. Barbara Burtness presented at the 75th Anniversary of the National Institute of Dental and Craniofacial Research (NIDCR).
- November 02, 2023Source: Fox Chase
YHN SPORE collaborators at FCCC have received a five-year, $13.3 million competitive grant renewal from the National Cancer Institute (NCI), part of the National Institutes of Health, to address cancer health disparities.
- July 31, 2023
Researchers have identified a novel subclass of HPV+ head and neck squamous cell carcinoma and demonstrated that treatment could be tailored by tumor type.
- May 02, 2023Source: OncLive
Barbara Burtness, MD, discusses preclinical data on the combination of VIC1911 and adavosertib in head and neck squamous cell carcinoma (HNSCC) and lung cancer.